DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Transderm Scop (Scopolamine Transdermal) - Confusional State - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Confusional State (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Transderm Scop (Scopolamine Transdermal) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Transderm Scop side effects in 58 year old female

Reported by a individual with unspecified qualification from United States on 2012-03-26

Patient: 58 year old female, weighing 63.5 kg (139.7 pounds)

Reactions: Confusional State, Hyperhidrosis, Hallucination, Skin Irritation

Drug(s) suspected as cause:
Transderm Scop



Possible Transderm Scop side effects in 35 year old female

Reported by a consumer/non-health professional from United States on 2012-02-23

Patient: 35 year old female

Reactions: Confusional State, Agitation, Hypersensitivity, Tachycardia, Normochromic Normocytic Anaemia, Hallucination, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydrocodone Bitartrate
    Dosage: 325 mg, unk

Transderm Scop
    Dosage: 1 df, once/single
    Indication: Procedural Nausea
    Start date: 2011-12-09
    End date: 2011-12-11

Oxycodone HCL and Acetaminophen
    Dosage: 5/325 mg, unk

Other drugs received by patient: Celebrex; Promethazine; Methocarbamol



Possible Transderm Scop side effects in 88 year old female

Reported by a consumer/non-health professional from United States on 2011-11-02

Patient: 88 year old female, weighing 43.5 kg (95.8 pounds)

Reactions: Confusional State, Incorrect Drug Administration Duration, Dementia Alzheimer's Type, Memory Impairment

Drug(s) suspected as cause:
Transderm Scop
    Dosage: 1 df, once/single
    Indication: Motion Sickness
    Start date: 2011-10-23
    End date: 2011-10-26

Transderm Scop
    Dosage: unk, unk

Exelon
    Dosage: 4.6 mg, qd
    Indication: Dementia Alzheimer's Type
    Start date: 2011-08-01

Other drugs received by patient: Aspirin; Synthroid; Celexa; Celexa; Lomotil; Vitamin D; Prevacid; Vitamin B-12



Possible Transderm Scop side effects in 32 year old female

Reported by a consumer/non-health professional from United States on 2011-10-25

Patient: 32 year old female

Reactions: Confusional State, Vomiting, Mydriasis, Hallucination, Visual, Nausea, Heart Rate Increased, Formication, Blindness, Tremor

Drug(s) suspected as cause:
Transderm Scop
    Dosage: 1 df, once/single
    Start date: 2011-10-08
    End date: 2011-10-09

Transderm Scop
    Dosage: 1 df, once/single
    Start date: 2011-10-08
    End date: 2011-10-08

Transderm Scop
    Dosage: 1 df, once/single
    Indication: Motion Sickness
    Start date: 2011-10-06
    End date: 2011-10-08



Possible Transderm Scop side effects in 28 year old female

Reported by a consumer/non-health professional from United States on 2011-10-21

Patient: 28 year old female, weighing 65.8 kg (144.7 pounds)

Reactions: Confusional State, Impaired Work Ability, Fear, Hyperhidrosis, Palpitations, DRY Mouth, Photophobia, Heart Rate Irregular, Hyperacusis, Condition Aggravated, Application Site Pain, Irritability, Therapeutic Response Decreased, Hyperaesthesia, Panic Attack, Insomnia, Vertigo, Withdrawal Syndrome, Feeling Abnormal, Application Site Irritation

Drug(s) suspected as cause:
Transderm Scop



Possible Transderm Scop side effects in 32 year old female

Reported by a consumer/non-health professional from United States on 2011-10-14

Patient: 32 year old female

Reactions: Confusional State, Vomiting, Mydriasis, Hallucination, Visual, Nausea, Heart Rate Increased, Formication, Blindness, Tremor

Drug(s) suspected as cause:
Transderm Scop
    Dosage: 1 df, once/single
    Start date: 2011-10-08
    End date: 2011-10-08

Transderm Scop
    Dosage: 1 df, once/single
    Start date: 2011-10-08
    End date: 2011-10-09

Transderm Scop
    Dosage: 1 df, once/single
    Indication: Motion Sickness
    Start date: 2011-10-06
    End date: 2011-10-08

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017